DAFTAR PUSTAKA

Adham, M. et al. (2012) ‘Nasopharyngeal carcinoma in Indonesia: epidemiology,

incidence,signs, and symptoms at presentation’, Chinese Journal of Cancer, 31(4), pp.
185–196. doi: 10.5732/cjc.011.10328.
American Joint Committee on Cancer (2018) AJCC cancer staging atlas: a companion to the 7th
editions of AJCC cancer staging manual and handbook. 2nd edn. New York: Springer.
Armstrong, R. W. et al. (1998) ‘Nasopharyngeal carcinoma in Malaysian Chinese: Salted fish
and other dietary exposures’, International Journal of Cancer, 77(2), pp. 228–235. doi:
10.1002/(SICI)1097-0215(19980717)77:2<228::AID-IJC11>3.0.CO;2-7.
Banerjee, S., Jha, H. C. and Robertson, E. S. (2015) ‘Regulation of the metastasis suppressor
Nm23-H1 by tumor viruses’, Naunyn-Schmiedeberg’s Archives of Pharmacology, 388(2),
pp. 207–224. doi: 10.1007/s00210-014-1043-8.
Cai, L. et al. (2015) ‘Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis
by regulating PTEN-dependent pathways in nasopharyngeal carcinoma’, Nature
Communications, 6. doi: 10.1038/ncomms8353.
Chen, S.-J. et al. (2010) ‘Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal
Carcinoma by Deep Sequencing’, PLoS ONE. Edited by D.-Y. Jin, 5(9), p. e12745. doi:
10.1371/journal.pone.0012745.
Chijioke, O. et al. (2013) ‘Innate immune responses against Epstein Barr virus infection’,
Journal of Leukocyte Biology, 94(6), pp. 1185–1190. doi: 10.1189/jlb.0313173.
Chua, M. L. K. et al. (2016) ‘Nasopharyngeal carcinoma’, The Lancet, 387(10022), pp. 1012–
1024. doi: 10.1016/S0140-6736(15)00055-0.
Colevas, A. D. et al. (2018) ‘NCCN Guidelines Insights: Head and Neck Cancers, Version
1.2018’, Journal of the National Comprehensive Cancer Network, 16(5), pp. 479–490. doi:
10.6004/jnccn.2018.0026.
Dai, W. et al. (2015) ‘Comparative methylome analysis in solid tumors reveals aberrant
methylation at chromosome 6p in nasopharyngeal carcinoma’, Cancer Medicine, 4(7), pp.
1079–1090. doi: 10.1002/cam4.451.
Dai, W. et al. (2016) ‘Genetic and epigenetic landscape of nasopharyngeal carcinoma’, Chinese
Clinical Oncology, 5(2), pp. 1–13. doi: 10.21037/cco.2016.03.06.
Flint, P. et al. (2015) Cummings Otolaryngology: Head and Neck Surgery. 6th edn. Philadelphia:
Springer.
Hu, K. et al. (2014) ‘Cancer of the Nasopharynx’, in Harrison, L. B., Sessions, R. B., and Kies,
M. S. (eds) Head and Neck Cancer: A Multidisciplinary Approach. 4th edn. Philadelphia:
Lippincott Williams & Wilkins.
Imig, J. et al. (2011) ‘microRNA profiling in Epstein–Barr virus-associated B-cell lymphoma’,
Nucleic Acids Research, 39(5), pp. 1880–1893. doi: 10.1093/nar/gkq1043.
Jayalie, V. F. et al. (2017) ‘Profile of Nasopharyngeal Carcinoma in Dr. Cipto Mangunkusumo
National Hospital, 2010’, eJournal Kedokteran Indonesia, 4(3). doi:
10.23886/ejki.4.7110.156-62.
Kang, D., Skalsky, R. L. and Cullen, B. R. (2015) ‘EBV BART MicroRNAs Target Multiple
Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival’, PLoS Pathogens, 11(6),
pp. 1–22. doi: 10.1371/journal.ppat.1004979.
Komite Penanggulangan Kanker Nasional (2017) Pedoman Nasional Pelayanan Kedokteran
Kanker Nasofaring. Jakarta: Kementerian Kesehatan RI.
Kuzembayeva, M., Hayes, M. and Sugden, B. (2014) ‘Multiple functions are mediated by the
miRNAs of Epstein-Barr virus’, Current Opinion in Virology, 7, pp. 61–65. doi:
10.1016/j.coviro.2014.04.003.
Lam, K.-O. et al. (2016) ‘Global Pattern of Nasopharyngeal Cancer: Correlation of Outcome
With Access to Radiation Therapy’, International Journal of Radiation
Oncology*Biology*Physics, 94(5), pp. 1106–1112. doi: 10.1016/j.ijrobp.2015.11.047.
Li, Y. Y. et al. (2017) ‘Exome and genome sequencing of nasopharynx cancer identifies NF-κB
pathway activating mutations’, Nature Communications, 8(1), p. 14121. doi:
10.1038/ncomms14121.
Lo, K.-W., Chung, G. T.-Y. and To, K.-F. (2012) ‘Deciphering the molecular genetic basis of
NPC through molecular, cytogenetic, and epigenetic approaches’, Seminars in Cancer
Biology, 22(2), pp. 79–86. doi: 10.1016/j.semcancer.2011.12.011.
Lung, M. L. et al. (2014) ‘The interplay of host genetic factors and Epstein-Barr virus in the
development of nasopharyngeal carcinoma’, Chinese Journal of Cancer, 33(11), pp. 556–
568. doi: 10.5732/cjc.014.10170.
Lung, R. W.-M. et al. (2009) ‘Modulation of LMP2A Expression by a Newly Identified Epstein-
 Barr Virus-Encoded MicroRNA miR-BART22’, Neoplasia, 11(11), pp. 1174-IN17. doi:
10.1593/neo.09888.
Mak, H. W. et al. (2015) ‘Clinical Outcome among Nasopharyngeal Cancer Patients in a Multi-
Ethnic Society in Singapore’, PLOS ONE. Edited by C.-Q. Gao, 10(5), p. e0126108. doi:
10.1371/journal.pone.0126108.
Marquitz, A. R. et al. (2012) ‘Infection of Epstein-Barr virus in a gastric carcinoma cell line
induces anchorage independence and global changes in gene expression’, Proceedings of
the National Academy of Sciences, 109(24), pp. 9593–9598. doi:
10.1073/pnas.1202910109.
Muller-Coan, B. G. et al. (2018) ‘Cancer Progression Goes Viral: The Role of Oncoviruses in
Aggressiveness of Malignancies’, Trends in Cancer, 4(7), pp. 485–498. doi:
10.1016/j.trecan.2018.04.006.
Muthiah, S. G. and MS, L. (2016) ‘Epstein-Barr Virus (EBV) and Its Association with
Nasopharyngeal Carcinoma (NPC): A Systematic Review’, International Journal of
Public Health and Clinical Sciences, 3(4), pp. 149–157.
Polesel, J. et al. (2011) ‘Tobacco smoking, alcohol drinking, and the risk of different histological
types of nasopharyngeal cancer in a low-risk population’, Oral Oncology, 47(6), pp. 541–
545. doi: 10.1016/j.oraloncology.2011.03.017.
Qiu, J. et al. (2011) ‘A Novel Persistence Associated EBV miRNA Expression Profile Is
Disrupted in Neoplasia’, PLoS Pathogens. Edited by S. H. Speck, 7(8), p. e1002193. doi:
10.1371/journal.ppat.1002193.
Raab-Traub, N. (2012) ‘Novel mechanisms of EBV-induced oncogenesis’, Current Opinion in
Virology, 2(4), pp. 453–458. doi: 10.1016/j.coviro.2012.07.001.
De Re, V. et al. (2020) ‘Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin
lymphoma and gastric cancer’, Infectious Agents and Cancer, 15(1), pp. 1–9. doi:
10.1186/s13027-020-00307-6.
Sakamoto, K. et al. (2017) ‘Next-generation sequencing of miRNAs in clinical samples of
Epstein-Barr virus-associated B-cell lymphomas’, Cancer Medicine, 6(3), pp. 605–618.
doi: 10.1002/cam4.1006.
Salehiniya, H. et al. (2018) ‘Nasopharyngeal Cancer in the World:Epidemiology,
Incidence,Mortality and Risk Factors’, World Cancer Research Journal, 5(1), pp. 1–8.
Schottenfeld, D. and Beebe-Dimmer, J. (2015) ‘The cancer burden attributable to biologic
agents’, Annals of Epidemiology, 25(3), pp. 183–187. doi:
10.1016/j.annepidem.2014.11.016.
Sinha, S. and Gajra, A. (2021) Nasopharyngeal Cancer. StatPearls. Treasure Island (FL).
Tsang, C. M. et al. (2019) ‘Pathogenesis of nasopharyngeal carcinoma : Histogenesis,
epstein-barr virus infection, and tumor microenvironment’, Nasopharyngeal Carcinoma:
From Etiology to Clinical Practice, pp. 45–64. doi: 10.1016/B978-0-12-814936-2.00003-
1.
Tsao, S. et al. (2015) ‘The role of Epstein–Barr virus in epithelial malignancies’, The Journal of
Pathology, 235(2), pp. 323–333. doi: 10.1002/path.4448.

Wang Y, Gou Z. et al. (2016) 'BART miRNAs : A Unimaginable Force In The Development Of
Nasopharyngeal Carcinoma', European Journal of Cancer Prevention , pp. 1-6

Watkinson, J. C. and Gilbert, R. W. (2012) Stell and Maran’s Textbook of Head and Neck
Surgery and Oncology. 5th edn. London: Hodder Arnold.
Wee, J. T. S. et al. (2019) ‘Is nasopharyngeal cancer really a “Cantonese cancer”?’, Chinese
Journal of Cancer, 29(5), pp. 517–526. doi: 10.5732/cjc.009.10329.
Wu, Q. et al. (2018) ‘Downregulation of EB virus miR-BART4 inhibits proliferation and
aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma’,
Biomedicine and Pharmacotherapy, 108(218), pp. 741–751. doi:
10.1016/j.biopha.2018.08.146.
Zeng, Z. et al. (2014) ‘Regulation network and expression profiles of Epstein-Barr virus-encoded
microRNAs and their potential target host genes in nasopharyngeal carcinomas’, Science
China Life Sciences, 57(3), pp. 315–326. doi: 10.1007/s11427-013-4577-y.
Zheng, C. X. et al. (1994) ‘Epstein-Barr Virus Infection, Salted Fish and Nasopharyngeal
Carcinoma: A case-control study in Southern’, Acta Oncologica, 33(8), pp. 867–872. doi:
10.3109/02841869409098448.
Zhu, J. Y. et al. (2009) ‘Identification of Novel Epstein-Barr Virus MicroRNA Genes from
Nasopharyngeal Carcinomas’, Journal of Virology, 83(7), pp. 3333–3341. doi:
10.1128/JVI.01689-08.